Tricuspid atresia surgery

Jump to: navigation, search

Tricuspid atresia Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Tricuspid Atresia from other Disorders

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Special Scenarios

Pregnancy

Case Studies

Case #1

Tricuspid atresia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tricuspid atresia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tricuspid atresia surgery

CDC on Tricuspid atresia surgery

Tricuspid atresia surgery in the news

Blogs on Tricuspid atresia surgery

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Tricuspid atresia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]

Surgery

Surgical Interventions

There are a number of interventional methods to address a tricuspid atresia. These include:

TA Fontan procedure.jpg


ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[1][2]

Surgical Options for Patients With Single Ventricle (DO NOT EDIT)[1][2]

Class I
"1. Surgeons with training and expertise in congenital heart disease (CHD) should perform operations for single-ventricle anatomy or physiology. (Level of Evidence: C)"

Evaluation and Follow-Up After Fontan Procedure (DO NOT EDIT)[1][2]

Class I
"1. Lifelong follow-up is recommended for patients after a Fontan type of operation; this should include a yearly evaluation by a cardiologist with expertise in the care of adult congenital heart disease (ACHD) patients. (Level of Evidence: C)"

Surgery for Adults With Prior Fontan Repair (DO NOT EDIT)[1][2]

Class I
"1. Surgeons with training and expertise in CHD should perform operations on patients with prior Fontan repair for single-ventricle physiology. (Level of Evidence: C)"
"2. Reoperation after Fontan is indicated for the following: (Level of Evidence: C)"
"a. Unintended residual atrial septal defect (ASD) that results in right-to-left shunt with symptoms and/or cyanosis not amenable to transcatheter closure. (Level of Evidence: C)"
"b. Hemodynamically significant residual systemic artery-to-pulmonary artery shunt, residual surgical shunt, or residual ventricle-to-pulmonary artery connection not amenable to transcatheter closure. (Level of Evidence: C)"
"c. Moderate to severe systemic atrioventricular (AV) valve regurgitation. (Level of Evidence: C)"
"d. Significant (greater than 30-mm Hg peak-to-peak) subaortic obstruction. (Level of Evidence: C)"
"e. Fontan pathway obstruction. (Level of Evidence: C)"
"f. Development of venous collateral channels or pulmonary arteriovenous malformation not amenable to transcatheter management. (Level of Evidence: C)"
"g. Pulmonary venous obstruction. (Level of Evidence: C)"
"h. Rhythm abnormalities, such as complete AV block or sick sinus syndrome, that require epicardial pacemaker insertion. (Level of Evidence: C)"
"i. Creation or closure of a fenestration not amenable to transcatheter intervention. (Level of Evidence: C)"
Class IIa
"1. Reoperation for Fontan conversion (i.e., revision of an atriopulmonary connection to an intracardiac lateral tunnel, intra-atrial conduit, or extracardiac conduit) can be useful for recurrent atrial fibrillation or flutter without hemodynamically significant anatomic abnormalities. A concomitant Maze procedure should also be performed. (Level of Evidence: C)"
Class IIb
"1. Heart transplantation may be beneficial for severe SV dysfunction or protein losing enteropathy (PLE). (Level of Evidence: C)"

References



Linked-in.jpg